 | • レポートコード：C9J06023 • 出版社/出版日：Prof Research / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥444,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥562,400 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥740,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界及び中国におけるゼルヤンツ（トファシチニブ）薬市場について調査・分析したレポートで、ゼルヤンツ（トファシチニブ）薬の世界市場動向、市場規模、主要企業情報などが含まれています。ゼルヤンツ（トファシチニブ）薬の種類別には、錠剤、徐放錠に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。 ・ゼルヤンツ（トファシチニブ）薬産業の概要 ・ゼルヤンツ（トファシチニブ）薬の製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国のゼルヤンツ（トファシチニブ）薬市場 2014年-2019年 ・世界及び中国のゼルヤンツ（トファシチニブ）薬市場現状 ・企業別分析：Pfizerなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・種類別分析：錠剤、徐放錠 ・世界及び中国のゼルヤンツ（トファシチニブ）薬市場予測 2019年-2024年 ・ゼルヤンツ（トファシチニブ）薬の産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国のゼルヤンツ（トファシチニブ）薬市場動向・課題・機会 ・新規プロジェクトへの提言・結論 |
Xeljanz (tofacitnib) Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Xeljanz (tofacitnib) Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Xeljanz (tofacitnib) Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Xeljanz (tofacitnib) Drug market covering all important parameters.
The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Xeljanz (tofacitnib) Drug industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Xeljanz (tofacitnib) Drug industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Xeljanz (tofacitnib) Drug Industry before evaluating its feasibility.
There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.
For competitor segment, the report includes global key players of Xeljanz (tofacitnib) Drug as well as some small players. At least 1 companies are included:
* Pfizer
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Xeljanz (tofacitnib) Drug market in gloabal and china.
* Tablets
* Extended-release Tablets
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Rheumatoid Arthritis
* Psoriatic Arthritis
* Other
Reasons to Purchase this Report:
* Estimates 2019-2024 Xeljanz (tofacitnib) Drug market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Chapter One Introduction of Xeljanz (tofacitnib) Drug Industry
1.1 Brief Introduction of Xeljanz (tofacitnib) Drug
1.2 Development of Xeljanz (tofacitnib) Drug Industry
1.3 Status of Xeljanz (tofacitnib) Drug Industry
Chapter Two Manufacturing Technology of Xeljanz (tofacitnib) Drug
2.1 Development of Xeljanz (tofacitnib) Drug Manufacturing Technology
2.2 Analysis of Xeljanz (tofacitnib) Drug Manufacturing Technology
2.3 Trends of Xeljanz (tofacitnib) Drug Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Company B
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Company C
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Company D
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Company E
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Company F
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Company G
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……
Chapter Four 2014-2019 Global and Chinese Market of Xeljanz (tofacitnib) Drug
4.1 2014-2019 Global Capacity, Production and Production Value of Xeljanz (tofacitnib) Drug Industry
4.2 2014-2019 Global Cost and Profit of Xeljanz (tofacitnib) Drug Industry
4.3 Market Comparison of Global and Chinese Xeljanz (tofacitnib) Drug Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Xeljanz (tofacitnib) Drug
4.5 2014-2019 Chinese Import and Export of Xeljanz (tofacitnib) Drug
Chapter Five Market Status of Xeljanz (tofacitnib) Drug Industry
5.1 Market Competition of Xeljanz (tofacitnib) Drug Industry by Company
5.2 Market Competition of Xeljanz (tofacitnib) Drug Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Xeljanz (tofacitnib) Drug Consumption by Application/Type
Chapter Six 2019-2024 Market Forecast of Global and Chinese Xeljanz (tofacitnib) Drug Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Xeljanz (tofacitnib) Drug
6.2 2019-2024 Xeljanz (tofacitnib) Drug Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Xeljanz (tofacitnib) Drug
6.4 2019-2024 Global and Chinese Supply and Consumption of Xeljanz (tofacitnib) Drug
6.5 2019-2024 Chinese Import and Export of Xeljanz (tofacitnib) Drug
Chapter Seven Analysis of Xeljanz (tofacitnib) Drug Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry
Chapter Eight Global and Chinese Economic Impact on Xeljanz (tofacitnib) Drug Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Xeljanz (tofacitnib) Drug Industry
Chapter Nine Market Dynamics of Xeljanz (tofacitnib) Drug Industry
9.1 Xeljanz (tofacitnib) Drug Industry News
9.2 Xeljanz (tofacitnib) Drug Industry Development Challenges
9.3 Xeljanz (tofacitnib) Drug Industry Development Opportunities
Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment
Chapter Eleven Research Conclusions of Global and Chinese Xeljanz (tofacitnib) Drug Industry
Tables and Figures
Figure Xeljanz (tofacitnib) Drug Product Picture
Table Development of Xeljanz (tofacitnib) Drug Manufacturing Technology
Figure Manufacturing Process of Xeljanz (tofacitnib) Drug
Table Trends of Xeljanz (tofacitnib) Drug Manufacturing Technology
Figure Xeljanz (tofacitnib) Drug Product and Specifications
Table 2014-2019 Xeljanz (tofacitnib) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Xeljanz (tofacitnib) Drug Capacity Production and Growth Rate
Figure 2014-2019 Xeljanz (tofacitnib) Drug Production Global Market Share
Figure Xeljanz (tofacitnib) Drug Product and Specifications
Table 2014-2019 Xeljanz (tofacitnib) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Xeljanz (tofacitnib) Drug Capacity Production and Growth Rate
Figure 2014-2019 Xeljanz (tofacitnib) Drug Production Global Market Share
Figure Xeljanz (tofacitnib) Drug Product and Specifications
Table 2014-2019 Xeljanz (tofacitnib) Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Xeljanz (tofacitnib) Drug Capacity Production and Growth Rate
Figure 2014-2019 Xeljanz (tofacitnib) Drug Production Global Market Share
Figure Xeljanz (tofacitnib) Drug Product and Specifications
Table 2014-2019 Xeljanz (tofacitnib) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Xeljanz (tofacitnib) Drug Capacity Production and Growth Rate
Figure 2014-2019 Xeljanz (tofacitnib) Drug Production Global Market Share
Figure Xeljanz (tofacitnib) Drug Product and Specifications
Table 2014-2019 Xeljanz (tofacitnib) Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Xeljanz (tofacitnib) Drug Capacity Production and Growth Rate
Figure 2014-2019 Xeljanz (tofacitnib) Drug Production Global Market Share
Figure Xeljanz (tofacitnib) Drug Product and Specifications
Table 2014-2019 Xeljanz (tofacitnib) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Xeljanz (tofacitnib) Drug Capacity Production and Growth Rate
Figure 2014-2019 Xeljanz (tofacitnib) Drug Production Global Market Share
Figure Xeljanz (tofacitnib) Drug Product and Specifications
Table 2014-2019 Xeljanz (tofacitnib) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Xeljanz (tofacitnib) Drug Capacity Production and Growth Rate
Figure 2014-2019 Xeljanz (tofacitnib) Drug Production Global Market Share
Figure Xeljanz (tofacitnib) Drug Product and Specifications
Table 2014-2019 Xeljanz (tofacitnib) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Xeljanz (tofacitnib) Drug Capacity Production and Growth Rate
Figure 2014-2019 Xeljanz (tofacitnib) Drug Production Global Market Share
……
……
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Capacity List
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Manufacturers Capacity Share List
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Manufacturers Capacity Share
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Manufacturers Production List
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Manufacturers Production Share List
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Manufacturers Production Share
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Capacity Production and Growth Rate
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Manufacturers Production Value List
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Production Value and Growth Rate
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Manufacturers Production Value Share List
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Manufacturers Production Value Share
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Xeljanz (tofacitnib) Drug Production
Table 2014-2019 Global Supply and Consumption of Xeljanz (tofacitnib) Drug
Table 2014-2019 Import and Export of Xeljanz (tofacitnib) Drug
Figure 2018 Global Xeljanz (tofacitnib) Drug Key Manufacturers Capacity Market Share
Figure 2018 Global Xeljanz (tofacitnib) Drug Key Manufacturers Production Market Share
Figure 2018 Global Xeljanz (tofacitnib) Drug Key Manufacturers Production Value Market Share
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Capacity List
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Capacity
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Capacity Share List
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Capacity Share
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Production List
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Production
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Production Share List
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Production Share
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Consumption Volume List
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Consumption Volume
Table 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Consumption Volume Share List
Figure 2014-2019 Global Xeljanz (tofacitnib) Drug Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Xeljanz (tofacitnib) Drug Consumption Volume Market by Application
Table 89 2014-2019 Global Xeljanz (tofacitnib) Drug Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Xeljanz (tofacitnib) Drug Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Xeljanz (tofacitnib) Drug Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Xeljanz (tofacitnib) Drug Consumption Volume Market by Application
Figure 2019-2024 Global Xeljanz (tofacitnib) Drug Capacity Production and Growth Rate
Figure 2019-2024 Global Xeljanz (tofacitnib) Drug Production Value and Growth Rate
Table 2019-2024 Global Xeljanz (tofacitnib) Drug Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Xeljanz (tofacitnib) Drug Production
Table 2019-2024 Global Supply and Consumption of Xeljanz (tofacitnib) Drug
Table 2019-2024 Import and Export of Xeljanz (tofacitnib) Drug
Figure Industry Chain Structure of Xeljanz (tofacitnib) Drug Industry
Figure Production Cost Analysis of Xeljanz (tofacitnib) Drug
Figure Downstream Analysis of Xeljanz (tofacitnib) Drug
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Xeljanz (tofacitnib) Drug Industry
Table Xeljanz (tofacitnib) Drug Industry Development Challenges
Table Xeljanz (tofacitnib) Drug Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Xeljanz (tofacitnib) Drugs Project Feasibility Study
世界のスニチニブ薬市場：市場規模・現状・予測 Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…- 世界のデュピュイトラン拘縮薬市場2019 The global Dupuytren Contracture Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Dupuytren Contracture Drug market status and forecast, categorizes the global Dupuytren Contracture Drug…
- NSCLC用標的薬物MEK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug MEK Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…
- 世界のデシタビン薬市場：市場規模・現状・予測 Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML).In 2018, the global Decitabine…
- コセンティクス薬市場：世界及び中国市場分析・予測（～2024年） Cosentyx- Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cosentyx- Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cosentyx- Drug manufacturers and is a va…